Latest

Learn how antibiotic-resistant UTI testing identifies ESBL, CRE, resistance genes, and antibiotic susceptibility, and how culture results guide treatment and follow-up.

Antibiotic-Resistant UTI Test: ESBL, CRE, Resistance Markers, and Culture Meaning

Learn what asymptomatic bacteriuria means, how a positive urine culture without UTI symptoms is interpreted, and when screening, treatment, or follow-up matters.

Asymptomatic Bacteriuria Test: Positive Culture Without Symptoms and When It Matters

Learn how bacteria in urine are interpreted using urinalysis, culture, colony count, symptoms, and sample quality, including when contamination or follow-up testing matters.

Bacteria in Urine Test: UTI, Contamination, Colony Count, and Culture Follow-Up

Learn how a catheter urine culture helps diagnose catheter-associated UTI, how samples are collected, and what colony counts, pyuria, resistance, and positive results mean.

Catheter Urine Culture Test: Catheter-Associated UTI and Culture Meaning

Learn how a chlamydia and gonorrhea urine NAAT works, how to collect first-catch urine, what positive or negative results mean, and when follow-up testing is needed.

Chlamydia and Gonorrhea Urine NAAT Test: STI Screening, Positive Result, and Meaning

Learn how to collect a clean-catch urine culture, reduce contamination, handle the sample correctly, and understand mixed flora, colony counts, repeat testing, and accurate results.

Clean-Catch Urine Culture Test: Sample Collection, Contamination, and Accurate Results

Diagnostics

Home Diagnostics Page 19

Understand BRCA1 and BRCA2 testing in prostate cancer, including hereditary risk, germline versus somatic variants, VUS meaning, DNA-repair biology, family implications, and targeted treatment options.

BRCA1 and BRCA2 Test for Prostate Cancer: Hereditary Risk, DNA Repair,...

Learn how circulating tumor DNA testing works in prostate cancer, which mutations and resistance markers it can detect, how to interpret negative results, and when liquid biopsy helps guide advanced disease treatment.

Circulating Tumor DNA Test for Prostate Cancer: Mutations, Resistance Markers, and...

Understand what a complexed PSA test measures, what high cPSA can mean, how it differs from total and free PSA, why modern use is limited, and which follow-up tests can clarify prostate cancer risk.

Complexed PSA Test: Prostate Cancer Risk, PSA Interpretation, and Follow-Up

Learn how the ConfirmMDx prostate test uses GSTP1, APC, and RASSF1 methylation after a negative biopsy, what positive and negative results mean, and how the assay may help guide repeat biopsy decisions.

ConfirmMDx Test: Prostate Cancer Epigenetic Marker and Repeat Biopsy Risk

Learn how the Decipher prostate genomic classifier score estimates metastasis and prognosis, how low, intermediate, and high scores are interpreted, and when testing may affect prostate cancer treatment decisions.

Decipher Prostate Genomic Classifier Test: Genomic Risk Score, Metastasis Risk, and...

Learn what the ExoDx Prostate urine test measures, how the 15.6 EPI cutoff relates to high-grade prostate cancer risk, and how results guide biopsy decisions.

ExoDx Prostate Test: Urine Exosome Biomarkers, High-Grade Prostate Cancer Risk, and...

Understand the free PSA test, percent free PSA ranges, why lower percentages raise prostate cancer risk, and how results can guide MRI or biopsy decisions.

Free PSA Test: Percent Free PSA, Prostate Cancer Risk, and Result...

Learn what a HOXB13 genetic test means, how the G84E variant affects hereditary prostate cancer risk, and what positive, negative, and family results can imply.

HOXB13 Genetic Test: Hereditary Prostate Cancer Risk and Family History

Metastatic Prostate Cancer Biomarker Panel: PSA, PSMA, HRR Genes, MSI, and...

Learn how the Oncotype DX Genomic Prostate Score measures tumor gene expression, what a 0–100 GPS result means, and how it can guide prostate cancer care.

Oncotype DX Genomic Prostate Score Test: Prostate Cancer Risk and Genomic...

Learn what a PCA3 urine test measures, how scores such as 25 are interpreted, and how PCA3 fits with repeat biopsy, PSA, MRI, and newer biomarkers.

PCA3 Urine Test: Prostate Cancer Risk, Repeat Biopsy, PSA Follow-Up, and...

Learn how the Prolaris test measures 31 cell-cycle genes, what higher or lower scores mean, and how results can refine prostate cancer surveillance and treatment.

Prolaris Test: Prostate Cancer Cell Cycle Score and Disease Aggressiveness

Learn how the ProMark prostate cancer test measures eight protein biomarkers, what a 1–100 score means, and how results can refine prognosis and surveillance decisions.

ProMark Test: Prostate Cancer Protein Biomarker Score and Prognosis

Prostate cancer biomarker panels combine PSA, free PSA, PHI, 4Kscore, PCA3, MRI, and clinical risk factors to guide biopsy decisions and assess significant cancer risk.

Prostate Cancer Biomarker Panel: PSA, Free PSA, PHI, 4Kscore, PCA3, and...

Prostate cancer HRR gene panels test BRCA1, BRCA2, ATM, CHEK2, PALB2, and related DNA-repair genes to guide hereditary risk assessment and precision treatment decisions.

Prostate Cancer HRR Gene Panel: BRCA, ATM, CHEK2, PALB2, and DNA...

The Prostate Health Index combines p2PSA, free PSA, and total PSA into a cancer risk score that can help refine prostate biopsy decisions when PSA alone is uncertain.

Prostate Health Index (PHI) Test: p2PSA, Free PSA, Total PSA, and...

1...181920...137 Page 19 of 137